Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adding specificity to artificial transcription activators.

Paramjit S Arora1

  • 1Department of Chemistry, New York University, New York, NY 10012, USA.

Chemistry & Biology
|March 31, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Photoredox-Catalyzed Lysine C(sp<sup>3</sup>)-H Functionalization for Peptide Editing.

Journal of the American Chemical Society·2026
Same author

Small Molecule Catalyst for Peptide Synthesis.

Journal of the American Chemical Society·2025
Same author

From Concepts to Inhibitors: A Blueprint for Targeting Protein-Protein Interactions.

Chemical reviews·2025
Same author

Reengineering of a Proteomimetic Pan-Ras Inhibitor into a Ras Degrader.

Angewandte Chemie (International ed. in English)·2025
Same author

C2230, a preferential use- and state-dependent CaV2.2 channel blocker, mitigates pain behaviors across multiple pain models.

The Journal of clinical investigation·2024
Same author

A peptidomimetic modulator of the Ca<sub>V</sub>2.2 N-type calcium channel for chronic pain.

Proceedings of the National Academy of Sciences of the United States of America·2023
Same journal

The Hedgehog Pathway Effector Smoothened Exhibits Signaling Competency in the Absence of Ciliary Accumulation.

Chemistry & biology·2017
Same journal

DIVERSE System: De Novo Creation of Peptide Tags for Non-enzymatic Covalent Labeling by In Vitro Evolution for Protein Imaging Inside Living Cells.

Chemistry & biology·2015
Same journal

Differential Regulation of Specific Sphingolipids in Colon Cancer Cells during Staurosporine-Induced Apoptosis.

Chemistry & biology·2015
Same journal

Synthetic Peptides as cGMP-Independent Activators of cGMP-Dependent Protein Kinase Iα.

Chemistry & biology·2015
Same journal

Unraveling the B. pseudomallei Heptokinase WcbL: From Structure to Drug Discovery.

Chemistry & biology·2015
Same journal

Vitamin C as Cancer Destroyer, Investigating Sulfhydration, and the Variability in CFTR Interactome.

Chemistry & biology·2015
See all related articles

Researchers developed artificial transcription activators that work in specific cell types. These synthetic activators require a yeast transcription complex component for effective gene activation.

Area of Science:

  • Molecular Biology
  • Synthetic Biology
  • Gene Regulation

Background:

  • Artificial transcription activators (ATAs) are engineered proteins designed to control gene expression.
  • Cell-type-specific gene regulation is crucial for development and disease.
  • Understanding transcription complex interactions is key to designing effective ATAs.

Purpose of the Study:

  • To design novel artificial transcription activators capable of cell-type-specific function.
  • To investigate the mechanism of transcriptional activation by ATAs.
  • To determine the role of specific transcription complex components in ATA-mediated activation.

Main Methods:

  • Peptide library screening to identify binding partners within the yeast transcription complex.
  • Engineering of artificial transcription activators incorporating selected peptides.

Related Experiment Videos

  • Assays to measure transcriptional activation in a cell-type-specific manner.
  • Functional analysis of ATA-mediated gene expression.

    • Main Results:

    • Identification of peptides that bind to a specific component of the yeast transcription complex.
    • Demonstration that the designed ATAs exhibit cell-type-specific transcriptional activation.
    • Evidence that the presence of the targeted yeast transcription complex component is essential for effective activation by the ATAs.

    Conclusions:

    • Artificial transcription activators can be engineered for precise cell-type-specific gene control.
    • The binding of ATAs to specific transcription complex components is critical for their function.
    • This work advances the design principles for synthetic gene regulation tools.